A carregar...
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
SIMPLE SUMMARY: In this review, we examined relevant clinical trial results with immune checkpoint inhibitors in patients with metastatic urothelial cancer. We also focused on the potential of immunotherapy in the adjuvant and neoadjuvant setting or as part of drug combinations. Finally, we briefly...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7795541/ https://ncbi.nlm.nih.gov/pubmed/33401585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010131 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|